Metabolic risk factors in responders to tesamorelin, a growth hormone-releasing factor (GRF) analogue, in HIV-infected patients with excess abdominal fat [abstract].
Nov 20, 2011
20 Nov 2011
Falutz J, Assaad H, Marsolais C, et al.
Location
16(suppl 2): A29. Proceedings of the 13th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV.
Agenda
Antiviral Therapy